Zobrazeno 1 - 10
of 121
pro vyhledávání: '"U, Falkmer"'
Autor:
E Gezelius, A Flou Kristensen, P O Bendahl, Y Hisada, S Risom Kristensen, L Ek, B Bergman, M Wallberg, U Falkmer, N Mackman, S Pedersen, M Belting
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0207387 (2018)
Coagulation activation and venous thromboembolism (VTE) are hallmarks of cancer; however, there is an unmet need of improved biomarkers for individualized anticoagulant treatment. The present sub-study of the RASTEN trial was designed to explore the
Externí odkaz:
https://doaj.org/article/fc411eef701d46fe82a4b9ad222dfd3f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
O Ahrens, U Falkmer, Willem E. Corver, Cees J. Cornelisse, Mårten Fernö, Olle Stål, Bo Baldetorp
Publikováno v:
Cytometry. 33:385-393
S-phase fraction (SPF), estimated in the flow cytometric DNA histogram, is a prognostic factor in breast cancer. There are, however, some inherent difficulties in the estimation of SPF, such as the influence of debris, aggregates, and normal cells. M
Publikováno v:
Acta Radiologica. 39:494-500
Purpose: the aim of the study was to explain why breast lesions are enhanced by contrast medium at MR imaging and to elucidate the histopathological basis for the overlap in the enhancement patterns of benign and malignant breast lesions Material and
Publikováno v:
European journal of cancer care. 21(4)
Health-related quality of life (QoL) is a goal in nutritional oncology but the association between nutritional status and QoL is rarely explored. The aim of the study was to investigate the association of nutritional assessment criteria with QoL in 5
Publikováno v:
International Journal of Cancer. 58:663-667
Loss of heterozygosity (LOH) at the site of the retinoblastoma (RB1) gene, at 13q14, has been shown to occur in a high proportion of ovarian cancer patients. Based on this, RB1 gene inactivation was studied in primary tumor cells from 15 patients wit
Publikováno v:
Acta Oncologica. 30:215-217
This is a presentation of some preliminary data from SPCG-I, a multicenter study started in 1984 by the Scandinavian Prostatic Cancer Group. It is a randomized double-blind study comparing estramustine phosphate and diethylstilbestrol in the primary
Autor:
E, Brenne, S, Kaasa, U, Falkmer, K O, Skaanes, O S, Husby, G, Myhr, G, Nilsen, E R, Bovim, R, Telhaug
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 119(22)
Cancer patients with spinal cord compression may develop irreversible neurological deficit. The clinical picture implies back pain and subsequent neurological deficit. There is always a danger of rapid deterioration of the patient's condition. If spi
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 119(19)
Dehydration is frequently encountered in patients with advanced cancer. Recently there has been increasing interest in the use of hypodermoclysis (HDC) for parenteral fluid replacement. There are numerous advantages over the intravenous route of admi